Stephen D. Schmidt

Stephen D. Schmidt

Vaccine Scientist
Verified email at nih.gov
Cited by 48430
Vaccine Development Assay Development SARS-CoV-2 HIV-1 Alzheimer's Disease
Mieczyslaw A. Piatyszek

Mieczyslaw A. Piatyszek

Biotechnology Consultant
Cited by 23801
cancer drug discovery HTS assay development
Ellen L. Berg

Ellen L. Berg

Alto Predict
Verified email at altopredict.com
Cited by 18202
Translational Biology Assay Development Drug Discovery Toxicology Predictive Models
Wei Zheng

Wei Zheng

National Center for Advancing Translational Sciences, National Institutes of Health
Verified email at mail.nih.gov
Cited by 17547
Drug discovery rare and neglected diseases high throughput screening assay development pharmacology
Christopher G Dowson

Christopher G Dowson

Professor of Microbiology, University of Warwick
Verified email at warwick.ac.uk
Cited by 17386
Microbiology biochemistry antibiotic resistance assay development drug discovery
Matthew D Hall

Matthew D Hall

National Center for Advancing Translational Sciences (NCATS)
Verified email at mail.nih.gov
Cited by 17276
experimental therapeutics cisplatin assay development covid-19 antivirals
Thomas Durcan

Thomas Durcan

The Neuro's Early Drug Discovery Unit (EDDU), McGill University
Verified email at mcgill.ca
Cited by 16636
stem cells brain organoids neurodegenerative disorders assay development
Anna Gerasimova,PhD

Anna Gerasimova,PhD

Associate Director of Bioinformatics, Quest Diagnostics
Verified email at questdiagnostics.com
Cited by 15765
Assay development NGS analysis Data analysis
Roeland Hanemaaijer

Roeland Hanemaaijer

TNO Metabolic Health Research
Verified email at tno.nl
Cited by 11264
matrix biology proteases collagen fibrosis assay development
Stephan Meister

Stephan Meister

Automation Consultant @ Beckman Coulter LS
Verified email at stephanmeister.com
Cited by 10399
automation drug screening assay development high content screening acoustic dispensing
1 - 10